Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Primate cell – per se
Patent
1994-12-07
1997-12-02
Ketter, James
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Primate cell, per se
C12N 508
Patent
active
056935331
ABSTRACT:
An adherent, stable, continuous human breast carcinoma cell line (GI-101A) has been produced from an infiltrating ductal breast carcinoma xenograft (GI-101) which has been grown and maintained in athymic mice for the past nine years. The GI-101A cells grow with an average doubling time of about 48 to about 72 hours. The cells display antigenic determinants consistent with those of the human breast tumor xenograft (GI-101) from which it was derived. The cell line, GI-101A, when injected subcutaneously into the subaxial area of athymic animals, such as athymic mice, produces tumors that spontaneously metastasize to distant organ sites, such as the lungs and lymph nodes. The cell line and the tumors that it produces may be used as model systems for study mechanisms responsible for metastatic behavior and for testing for new as well as screening for effective new anti-cancer drug therapies.
REFERENCES:
Hurst et. al 1993 Br. J. Cancer 68:274-276.
Schwartz, M.K. 1994 In. Antigen & Antibody Molecular Engineering in Breast Cancer Diagnosis & Treatment (ed.) R.L. Ceriani pp. 41-53, Plenum Press. N.Y.
Emma Dennis
Hurst Josephine
Raney Shula
Ketter James
The Goodwin Institue for Cancer Research
Yucel Irem
LandOfFree
Human breast carcinoma cell line capable of production of a spon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human breast carcinoma cell line capable of production of a spon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human breast carcinoma cell line capable of production of a spon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-800674